p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
about
Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.Prognostic and predictive factors in the adjuvant treatment of breast cancer.A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer Risk.p53 mutations and expression in breast carcinoma in situ.Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distributionHigh frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence populationAllelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-upSensitive and reliable PCR and sequencing used to detect p53 point mutations in fine needle aspirates of the breast.The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer.Biological indices in the assessment of breast cancer.Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma.Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma.Histological and immunohistochemical analysis of apocrine breast carcinoma.Histological classification of invasive ductal carcinoma and the biological parameters in breast cancer.HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Loss of heterozygosity in ductal carcinoma in situ of the breast.Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer.Synchronous liver metastases of intracystic papillary carcinoma with invasion of the breast.Detection of p53 gene mutations in aspiration biopsy specimens from suspected breast cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
P2860
Q33395114-8A5C1C99-0362-4FCE-B945-67246335C0B9Q33810039-52DA1AA8-FE3A-4548-B5C5-6101544346F9Q34642788-5B50F46B-6785-4EB9-977F-BB633E4255B8Q35176681-D7C2D1E3-F942-4724-BFBF-70CD4F4DFD47Q35793421-3CFF0F7C-F378-46D7-966E-405A5578AB33Q35846896-0EC356D1-830D-426E-870B-759016401C6DQ36135744-6DED4812-F2E0-48C8-9507-9BB58549D9C3Q36138654-C1128C0E-DF98-438E-B040-75D9485B2DC7Q36291835-F86E667F-4498-41E1-B5FE-3BDD320ACBFEQ37219047-AFC9661B-BB6F-4E79-9572-F3FFC97DA8ECQ37326072-6F46BBA7-1380-47A6-B8B5-2C3EE7BF797BQ37496869-9663E756-A47B-4B91-B36B-A8124FD08DA7Q37730372-DE9DAA85-608D-4F58-950C-D3435E2376F4Q38483058-961B3ACD-39E5-46E2-B0A8-853BC916BD07Q40848953-08432F1B-229D-4F26-825F-71D1D05D9E3DQ43602029-4AE0D664-526C-4C43-8C83-EFD613A4753BQ43997335-04422740-8ECE-41E3-BE60-D763CE3BDD62Q44115152-E6F098F4-0CFA-4B64-962E-CA26D6F9C552Q44433727-5F39298C-BB53-4460-A1A4-775D51E9B6C5Q45254374-EC742651-7A46-4F9E-9B1C-06794E886134Q46699535-39E9963B-6333-4F25-98E6-00BD1E90902FQ49179955-69ECCB0D-306E-45BB-9D7F-BC312CBEC0EBQ53450887-9803FA4E-1F44-4A22-ACAD-46BAA870B3CEQ53459051-BF044D9E-3AD3-4D7A-8E90-B1825BEFE084Q53563423-5E8E32CD-646C-4C56-8066-E72DA31D7A0DQ55419803-E26FF87C-CCC1-47E4-A380-37EA7AE42B1C
P2860
p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@en
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@nl
type
label
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@en
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@nl
prefLabel
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@en
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@nl
P2093
P2860
P1476
p53 mutations and c-erbB-2 amp ...... omas of high histologic grade.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1993.TB00149.X
P577
1993-04-01T00:00:00Z